Skip to main content
Premium Trial:

Request an Annual Quote

NimbleGen Acquires UT Southwestern Spin-off Light Biology

NEW YORK, March 9 (GenomeWeb News) - NimbleGen Systems of Madison, Wis., has acquired Light Biology, a microarray technology company spun out of the University of Texas Southwestern in 2001.

Financial terms of the acquisition were not provided.

Light Biology was founded to commercialize a microarray fabrication technique developed by Harold "Skip" Garner, a professor of biochemistry and internal medicine at UT Southwestern. The method, called Digital Optical Chemistry, uses Texas Instruments' Digital Light Processing technology to manufacture DNA microarrays. According to Light Biology, the DOC process is quicker and more cost effective than previous microarray manufacturing methods, and will enable researchers to create customized arrays "in a matter of hours."

NimbleGen has acquired all of Light Biology's assets and patent rights to the DOC technology. As part of the acquisition agreement, Garner will join NimbleGen's scientific advisory board.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.